Overview of Dr. Herold
Dr. Kevan Herold is an endocrinologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 38 years. Dr. Herold accepts several types of health insurance, listed below. He is one of 58 doctors at Yale-New Haven Hospital who specialize in Endocrinology. He has more than 100 publications and over 500 citings.
Office
789 Howard Avenue 2nd Floor
Dana Building
New Haven, CT 06510
Education & Training
- University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1986
- Temple University HospitalResidency, Internal Medicine, 1979 - 1982
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979
Certifications & Licensure
- CT State Medical License 2006 - 2025
- NY State Medical License 1998 - 2025
- IL State Medical License 1982 - 1999
- PA State Medical License 1981 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
- Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes Start of enrollment: 2005 Sep 01
- Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes.Maria J Redondo, David Cuthbertson, Andrea K Steck, Kevan C Herold, Richard Oram
Diabetologia. 2024-12-13 - Reversing diabetes with your own cells: Closer to the dream.Romi Genosar, Magdalena Maria Coman, Kevan C Herold
The Journal of Clinical Endocrinology and Metabolism. 2024-12-13 - Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.Alfonso Galderisi, Emily K Sims, Carmella Evans-Molina, Alessandra Petrelli, David Cuthbertson
Diabetologia. 2024-11-19
Journal Articles
- A Call for Improved Reporting of Human Islet Characteristics in Research ArticlesSteven E Kahn, Kevan C Herold, Maureen Gannon, Diabetologia
- Identification and Analysis of Islet Antigen–Specific CD8+ T Cells with T Cell LibrariesKevan C Herold, Andrea K Steck, The Journal of Immunology
- Reprogramming Human T Cell Function and Specificity with Non-Viral Genome TargetingNeil Romberg, Antoni Ribas, Michael R Lee, Ruby Yu, Gary M Kupfer, Julia Carnevale, Jonathan H Esensten, P Jonathan Li, Han Li, Kevan C Herold, Alexander Marson, Nature
- Join now to see all
Press Mentions
- In a 1st, Scientists Reversed Type 1 Diabetes by Reprogramming a Person's Own Fat CellsOctober 31st, 2024
- 5 Medical Advances That Will Change Patient CareMay 4th, 2023
- Are We Proof That a New Drug to Stop Diseases like Arthritis and Type 1 Diabetes Really DOES Work?April 3rd, 2023
- Join now to see all
Grant Support
- Human And Translational ImmunologyNational Institute Of Allergy And Infectious Diseases2010–2011
- Type 1 Diabetes Trialnet: Clinical Center At Yale University (U01)National Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Yale Autoimmunity Center Of ExcellenceNational Institute Of Allergy And Infectious Diseases2009–2011
- Administrative Core A, Component Of Yale Autoimmunity Center Of ExcellenceNational Institute Of Allergy And Infectious Diseases2009–2011
- Innate And Adaptive Immune Responses In Pre-Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Phase II Trial Of Hokt3gamma 1 (Ala-Ala) In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Type 1 Diabetes Trialnet: Clinical Center At Columbia UniversityNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Type 1 Diabetes Trialnet: Clin Ctr At Columbia Universi*National Institute Of Diabetes And Digestive And Kidney Diseases2006
- Phase II Trial Of Hokt3gamma 1 (Ala-Ala) In IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Islet Growth In NOD Mice Tolerant To Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Safety And PK Of Hokt3yl (Ala-Ala) In TidmNational Center For Research Resources2005
- Islet Transplants With Renal AllograftsNational Center For Research Resources2005
- Islet Growth In NOD Mice Tolerant To Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Combination Of Anti-Cd3 And Ag-Specific ImmunotherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Phase II Multiple Dose Treatment Of Type 1 Diabetes Mellitus With Hokt3gammalNational Center For Research Resources2004–2005
- Hokt3yl(Ala-Ala) In New Onset Type 1 Diabetes MellitusNational Center For Research Resources2004–2005
- Type 1 Diabetes Trialnet: Clin Ctr At Columbia Universi*National Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Phase I/II Trial Of Hokt3(1(Ala-Ala) In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
- Hokt3yl (Ala Ala) In New Onset Type I Diabetes MellitusNational Center For Research Resources2000–2002
- T Cell Activation And Repertoire In Insulin Dependent Diabetes / Anti CD40L TrialNational Institute Of Allergy And Infectious Diseases1999–2002
- Type 1 Diabetes Trialnet:Columbia UniversityNational Institute Of Diabetes And Digestive And Kidney Diseases2001
- Clinical Research Training In Immunosuppression And DiabNational Center For Research Resources2000
- Diabetes Prevention Trial--Type I DiabetesNational Center For Research Resources1996–1997
- Immunoregulation Of IDDMNational Institute Of Diabetes And Digestive And Kidney Diseases1995
- Islet Cell Reactive T-Lymphocytes In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Immune Mechanism For Preventing Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
- Islet Cell Reactive T Lymphocytes In Murine DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1993
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Connecticare FlexPOS
GHI PPO
Great West PPOHealth Alliance PPO
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Wellmark Alliance Select - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: